CO2024000322A2 - Composiciones de levadura fisiológicamente aceptables para uso en el tratamiento de un trastorno gastrointestinal. - Google Patents
Composiciones de levadura fisiológicamente aceptables para uso en el tratamiento de un trastorno gastrointestinal.Info
- Publication number
- CO2024000322A2 CO2024000322A2 CONC2024/0000322A CO2024000322A CO2024000322A2 CO 2024000322 A2 CO2024000322 A2 CO 2024000322A2 CO 2024000322 A CO2024000322 A CO 2024000322A CO 2024000322 A2 CO2024000322 A2 CO 2024000322A2
- Authority
- CO
- Colombia
- Prior art keywords
- physiologically acceptable
- boulardii
- cerevisiae
- marxianus
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/165—Yeast isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
- C12N1/185—Saccharomyces isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21382576 | 2021-06-30 | ||
| EP22382114 | 2022-02-11 | ||
| PCT/EP2022/068192 WO2023275323A1 (en) | 2021-06-30 | 2022-06-30 | Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2024000322A2 true CO2024000322A2 (es) | 2024-03-18 |
Family
ID=82308337
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2024/0000322A CO2024000322A2 (es) | 2021-06-30 | 2024-01-16 | Composiciones de levadura fisiológicamente aceptables para uso en el tratamiento de un trastorno gastrointestinal. |
| CONC2024/0000323A CO2024000323A2 (es) | 2021-06-30 | 2024-01-16 | Composiciones de levadura fisiológicamente aceptables y usos de las mismas. |
| CONC2024/0000344A CO2024000344A2 (es) | 2021-06-30 | 2024-01-16 | Composiciones de levadura fisiológicamente aceptables y usos de las mismas. |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2024/0000323A CO2024000323A2 (es) | 2021-06-30 | 2024-01-16 | Composiciones de levadura fisiológicamente aceptables y usos de las mismas. |
| CONC2024/0000344A CO2024000344A2 (es) | 2021-06-30 | 2024-01-16 | Composiciones de levadura fisiológicamente aceptables y usos de las mismas. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20240316131A1 (cg-RX-API-DMAC7.html) |
| EP (3) | EP4362710A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2024524501A (cg-RX-API-DMAC7.html) |
| KR (3) | KR20240037257A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2022302361A1 (cg-RX-API-DMAC7.html) |
| CA (3) | CA3223134A1 (cg-RX-API-DMAC7.html) |
| CO (3) | CO2024000322A2 (cg-RX-API-DMAC7.html) |
| IL (3) | IL309525A (cg-RX-API-DMAC7.html) |
| MX (3) | MX2023015507A (cg-RX-API-DMAC7.html) |
| WO (3) | WO2023275325A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3223134A1 (en) * | 2021-06-30 | 2023-01-05 | Carlos DE LECEA | Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder |
| WO2025104171A1 (en) * | 2023-11-14 | 2025-05-22 | Ab Mauri (Uk) Ltd | Physiologically acceptable microbiological compositions comprising lactic acid bacteria and kluyveromyces marxianus yeast and uses thereof |
| CN117866854B (zh) * | 2024-03-08 | 2024-06-07 | 广州同康生物科技有限公司 | 修复胃肠黏膜损伤的罗伊氏粘液乳杆菌bn01及其后生元 |
| WO2025233827A1 (en) * | 2024-05-10 | 2025-11-13 | A. Menarini International Licensing S.A. | Beneficial complementary symbiotic and mineral mix |
| EP4732843A1 (en) * | 2024-10-22 | 2026-04-29 | Lesaffre et Compagnie | Live saccharomyces cerevisiae strains for the treatment of bone-loss disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101654537B1 (ko) | 2007-12-26 | 2016-09-06 | 르샤프르 에 꽁빠니 | 인간 및/또는 동물 영양을 위한 조성물, 이의 용도 및 효모균 |
| EA202090769A1 (ru) * | 2018-05-04 | 2020-06-11 | Борис Славинович ФАРБЕР | Пищевая, косметическая и фармацевтическая композиция с иммуномодулирующим и протективным антивирусным эффектом |
| CN111944725B (zh) * | 2020-08-24 | 2021-12-07 | 汤臣倍健股份有限公司 | 一种副干酪乳杆菌207-27及其应用 |
| CA3223134A1 (en) * | 2021-06-30 | 2023-01-05 | Carlos DE LECEA | Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder |
-
2022
- 2022-06-30 CA CA3223134A patent/CA3223134A1/en active Pending
- 2022-06-30 JP JP2023581073A patent/JP2024524501A/ja active Pending
- 2022-06-30 AU AU2022302361A patent/AU2022302361A1/en active Pending
- 2022-06-30 AU AU2022303105A patent/AU2022303105A1/en active Pending
- 2022-06-30 IL IL309525A patent/IL309525A/en unknown
- 2022-06-30 MX MX2023015507A patent/MX2023015507A/es unknown
- 2022-06-30 KR KR1020247003284A patent/KR20240037257A/ko active Pending
- 2022-06-30 WO PCT/EP2022/068197 patent/WO2023275325A1/en not_active Ceased
- 2022-06-30 MX MX2023015498A patent/MX2023015498A/es unknown
- 2022-06-30 KR KR1020247003278A patent/KR20240037981A/ko active Pending
- 2022-06-30 AU AU2022303106A patent/AU2022303106A1/en active Pending
- 2022-06-30 CA CA3223303A patent/CA3223303A1/en active Pending
- 2022-06-30 JP JP2023581076A patent/JP2024526282A/ja active Pending
- 2022-06-30 KR KR1020247003283A patent/KR20240037256A/ko active Pending
- 2022-06-30 MX MX2023015516A patent/MX2023015516A/es unknown
- 2022-06-30 US US18/575,600 patent/US20240316131A1/en active Pending
- 2022-06-30 EP EP22735002.2A patent/EP4362710A1/en active Pending
- 2022-06-30 WO PCT/EP2022/068151 patent/WO2023275293A1/en not_active Ceased
- 2022-06-30 WO PCT/EP2022/068192 patent/WO2023275323A1/en not_active Ceased
- 2022-06-30 EP EP22735003.0A patent/EP4362711A1/en active Pending
- 2022-06-30 CA CA3223136A patent/CA3223136A1/en active Pending
- 2022-06-30 JP JP2023581075A patent/JP2024524502A/ja not_active Withdrawn
- 2022-06-30 EP EP22735004.8A patent/EP4362712A1/en active Pending
- 2022-06-30 US US18/575,677 patent/US20240325475A1/en active Pending
- 2022-06-30 US US18/575,656 patent/US20240293488A1/en active Pending
- 2022-06-30 IL IL309519A patent/IL309519A/en unknown
- 2022-06-30 IL IL309521A patent/IL309521A/en unknown
-
2024
- 2024-01-16 CO CONC2024/0000322A patent/CO2024000322A2/es unknown
- 2024-01-16 CO CONC2024/0000323A patent/CO2024000323A2/es unknown
- 2024-01-16 CO CONC2024/0000344A patent/CO2024000344A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2023015516A (es) | 2024-03-15 |
| CA3223303A1 (en) | 2023-01-05 |
| WO2023275323A9 (en) | 2023-03-09 |
| EP4362711A1 (en) | 2024-05-08 |
| US20240316131A1 (en) | 2024-09-26 |
| US20240293488A1 (en) | 2024-09-05 |
| MX2023015498A (es) | 2024-03-04 |
| JP2024526282A (ja) | 2024-07-17 |
| CA3223134A1 (en) | 2023-01-05 |
| US20240325475A1 (en) | 2024-10-03 |
| EP4362712A1 (en) | 2024-05-08 |
| CO2024000323A2 (es) | 2024-03-18 |
| KR20240037257A (ko) | 2024-03-21 |
| CA3223136A1 (en) | 2023-01-05 |
| JP2024524502A (ja) | 2024-07-05 |
| JP2024524501A (ja) | 2024-07-05 |
| KR20240037256A (ko) | 2024-03-21 |
| WO2023275325A1 (en) | 2023-01-05 |
| AU2022303105A1 (en) | 2024-02-01 |
| IL309519A (en) | 2024-02-01 |
| WO2023275323A1 (en) | 2023-01-05 |
| WO2023275293A1 (en) | 2023-01-05 |
| AU2022303106A1 (en) | 2024-02-01 |
| IL309521A (en) | 2024-02-01 |
| MX2023015507A (es) | 2024-04-26 |
| AU2022302361A1 (en) | 2024-02-01 |
| EP4362710A1 (en) | 2024-05-08 |
| KR20240037981A (ko) | 2024-03-22 |
| CO2024000344A2 (es) | 2024-04-18 |
| IL309525A (en) | 2024-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2024000322A2 (es) | Composiciones de levadura fisiológicamente aceptables para uso en el tratamiento de un trastorno gastrointestinal. | |
| MX2018011348A (es) | Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades. | |
| BRPI0820068B8 (pt) | uso de cepa de levedura e/ou de uma composição compreendendo cepa de levedura para preparação de um medicamento | |
| CL2017001191A1 (es) | Compuestos derivados de carbamoilpiridona policíclicos; composición farmacéutica que los comprende; y su uso para el tratamiento de una infección de vih en un humano que tiene o se encuentra en riesgo de tener la infección. | |
| AR107967A1 (es) | Ácido hialurónico modificado, método para su preparación y usos del mismo | |
| CU20130033A7 (es) | Imidazopiridazinas sustituidas | |
| BR112012010992A2 (pt) | formulação de gel de polissacarídeo tendo distribuição de agente bioativo em estágios múltiplos | |
| MY152710A (en) | Oral compositions containing extracts of garcinia mangostana l. and related methods | |
| MX357150B (es) | Composicion de acaros que comprende un acaro depredador y una presa inmovilizada que se pone pone en contacto con un agente reductor de hongos y metodos y usos relacionados con el uso de dicha composicion. | |
| PE20191044A1 (es) | Composicion farmaceutica | |
| WO2019067405A3 (en) | Ketogenic diet compatible fenfluramine formulation | |
| WO2014081702A3 (en) | Synthetic linear apelin mimetics for the treatment of heart failure | |
| BR112012022337A2 (pt) | composição e respectivos método de preparação e uso de quantidade eficaz | |
| BR112022015768A2 (pt) | Métodos de tratamento e prevenção de arritmias de enxerto | |
| MX2020013621A (es) | Composiciones y metodos de tratamiento de vih. | |
| TR201818784T4 (tr) | Selenyum İle Kombinasyon Halinde Aronia Sp.'nin Bir Ekstraktını İçeren Bağışık Uyarıcı Terkip | |
| WO2010077867A3 (en) | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus | |
| PE20211479A1 (es) | Composicion farmaceutica y metodo de fabricacion | |
| CL2011001775A1 (es) | Composicion veterinaria antiparasitaria que comprende doramectina, aceite de algodon, benzoato de bencilo y uno o mas entre conservantes, excipientes y vitamina liposoluble. | |
| WO2011141113A3 (de) | Kombination aus vitamin k und nikotinamid | |
| AR043173A1 (es) | Uso de dipiridamol en combinacion con acido acetilsalicilico y un antagonista de angiotensina ii para la prevencion de accidente cerebrovascular | |
| MX2022003398A (es) | Composicion micelar inmunoestimulante. | |
| MX2019008782A (es) | Composicion sinergica para el mantenimiento del equilibrio saludable de la microflora. | |
| MY197711A (en) | Use of compositions of water/alcohol extracts of antrodia cinnamomea cut-log wood cultivated fruiting body and solid-state cultivated mycelium as auxiliaries for anti-cancer agents | |
| CO2018013350A2 (es) | Una composición inmunogénica para el tratamiento del cáncer y métodos para preparar la misma |